Bruker Corp at JPMorgan Healthcare Conference Transcript
Hi. Welcome everybody. This is Casey Woodring Woodring from the Life Science Tools and Diagnostics team. Pleased to be joined by the management team of Brooker. This is a standard 40-minute session. We'll do corporate presentation and then Q&A afterwards. Frank, take it away.
Good morning everybody. Thank you, Casey.
Well, good to see many familiar faces. Welcome once again back to San Francisco and the JPMorgan conference. I'll give you an incremental evolutionary, presentation today and an update on the key themes for Brooker in 2026. There'll be some new insights and some new opportunities.
But I don't think there'll be any rabbits out of the hat, so to speak. So, what are the themes for Brucker in 2026? Let's jump right into it.
After a very significant 70% revenue jump between 2020 and 2024, with 25% admittedly being a rough year. Our focus is, for the, not only this year, but for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
